How Much Upside is Left in Castle Biosciences (CSTL)? Wall Street Analysts Think 50.08%

Core Viewpoint - Castle Biosciences, Inc. (CSTL) shows potential for significant upside, with a mean price target of $35.63 indicating a 50.1% increase from the current price of $23.74 [1] Price Targets - The average price target consists of eight estimates ranging from $30.00 to $41.00, with a standard deviation of $3.54, suggesting a consensus among analysts [2] - The lowest estimate indicates a 26.4% increase, while the highest suggests a 72.7% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding price movement [9] Analyst Sentiment - Analysts have shown increasing optimism about CSTL's earnings prospects, with a strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, one estimate has increased, leading to a 1.5% rise in the Zacks Consensus Estimate [12] Zacks Rank - CSTL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Conclusion on Price Movement - While the consensus price target may not reliably indicate the extent of potential gains, it does provide a useful guide for the direction of price movement [14]